Caribou Biosciences (CRBU) Net Margin (2020 - 2026)
Caribou Biosciences' (CRBU) quarterly Net Margin came in at 1172.67% in Q1 2026, up 65614.0% year-on-year from N/an in Q1 2025, and down 59.86% on a QoQ basis from 733.54% in Q4 2025.
Caribou Biosciences (CRBU) Net Margin (2020 - 2026) Analysis & Trends
Caribou Biosciences (CRBU) has 7 years of Net Margin data on file, last reported at 1172.67% in Q1 2026.
- On a quarterly basis, Net Margin rose 65614.0% year-over-year to 1172.67% in Q1 2026; TTM through Mar 2026 was 1224.29%, a 95376.0% increase from a year earlier, with the FY2025 full-year figure at 1327.4%, up 16454.0% from the prior year.
- Net Margin for Q1 2026 stood at 1172.67%, down from 733.54% in the prior quarter.
- Over the last five years, Net Margin for CRBU reached as high as 126.26% in Q3 2023 and fell as low as 3759.63% in Q3 2024.
- Historically, Net Margin has averaged 1595.03% across 5 years, with a median of 1556.83% in 2022.
- Across the five-year window, Net Margin sank 363337 bps in 2024 and jumped 228566 bps in 2025, its largest moves.
- Year by year, Net Margin stood at 841.68% in 2022, then declined by 25 bps to 1055.82% in 2023, then tumbled by 84 bps to 1940.64% in 2024, then surged by 62 bps to 733.54% in 2025, then sank by 60 bps to 1172.67% in 2026.
- Per Business Quant data, the three most recent Net Margin figures were 1172.67% in Q1 2026, 733.54% in Q4 2025, and 1473.98% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15.02% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Caribou Biosciences | 156.25 Mn | 38.63 Mn | - | -1,172.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,172.67% |
| Dec 31, 2025 | -733.54% |
| Sep 30, 2025 | -1,473.98% |
| Jun 30, 2025 | -1,790.06% |
| Mar 31, 2025 | -1,828.81% |
| Dec 31, 2024 | -1,940.64% |
| Sep 30, 2024 | -3,759.63% |
| Jun 30, 2024 | -1,633.52% |
| Mar 31, 2024 | -3,596.54% |
| Dec 31, 2023 | -1,055.82% |
| Sep 30, 2023 | -126.26% |
| Jun 30, 2023 | -2,041.68% |
| Mar 31, 2023 | -897.23% |
| Dec 31, 2022 | -841.68% |
| Sep 30, 2022 | -1,556.83% |
| Jun 30, 2022 | -1,815.29% |
| Mar 31, 2022 | -851.28% |
| Dec 31, 2021 | -722.12% |
| Sep 30, 2021 | -527.38% |
| Jun 30, 2021 | -969.58% |